Oncotarget

Research Papers:

Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)

Zhiyuan Tang _, Qin Shen, Hao Xie, Xiaoyu Zhou, Jun Li, Jian Feng, Hua Liu, Wei Wang, Shu Zhang and Songshi Ni

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:46253-46262. https://doi.org/10.18632/oncotarget.10086

Metrics: PDF 1377 views  |   HTML 2187 views  |   ?  


Abstract

Zhiyuan Tang1, Qin Shen1, Hao Xie2, Xiaoyu Zhou1, Jun Li1, Jian Feng1, Hua Liu1, Wei Wang3, Shu Zhang3, Songshi Ni1

1Department of Respiratory Medicine, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China

2Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China

3Department of Pathology, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China

Correspondence to:

Songshi Ni, email: jsntnss@163.com

Keywords: fatty acid binding protein-3(FABP3), fatty acid binding protein-4(FABP4), non-small cell lung cancer, immunohistochemistry, prognosis

Received: April 03, 2016     Accepted: May 29, 2016     Published: June 15, 2016

ABSTRACT

Fatty acid binding proteins (FABPs) are intracellular lipid-binding proteins that are involved in a variety of biological cellular processes, including tumorigenesis. In this study, we explored the expression pattern of FABP3 and FABP4 in non-small cell lung cancer (NSCLC) as well as their roles in prognosis. We determined mRNA expression of FABP3 and FABP4 in matched pairs of cancerous and non-cancerous fresh frozen tissues from 30 NSCLC patients. Tissue microarray immunohistochemical analysis (TMA-IHC) was applied to determine the protein expression of FABP3 and FABP4 in 281 cancerous and 121 matched adjacent non-cancerous tissue samples. Our results showed that both mRNA and protein expression of FABP3 and FABP4 were significantly higher in cancerous tissues when compared to non-cancerous tissues. Furthermore, high expression of FABP3 or FABP4 in NSCLC was significantly associated with advanced tumor node metastasis (TNM) stage and had a negative impact on the overall survival of NSCLC patients. Concurrent high expression of FABP3 and FABP4 was significantly related to TNM stage. In conclusion, our research demonstrated that high FABP3 or FABP4 expression had strong prognostic value for overall survival in NSCLC. Detection of FABP3 and FABP4 cooperatively was helpful to predict the prognosis of NSCLC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 10086